The Mandalorian and Grogu Achieves Record Rotten Tomatoes Audience Score Amid CriticAudience Divide The Turnaround Leader Who Rejected Silicon Valleys GrowthAtAllCosts Playbook Moroccos Tourism Initiative in Western Sahara Economic Potential Amid Geopolitical Tensions PutinXi Talks Set to Revive Power of Siberia 2 Gas Pipeline Amid Energy Market Turmoil HRS Aluglaze Shares Surge After Strong FY26 Results Revenue Jumps 60 US Shale Producers Gradually Increase Output Amid Price Discipline Omnicom Q1 2026 Earnings EPS Beats Estimates as Agency Demand Remains Resilient Meridian Corporation MRBK Q1 2026 Earnings EPS Misses Estimates but Stock Gains Slightly BURU Q3 2023 Earnings PreRevenue Loss of 014 per Share as Strategic Developments Underway ON Q1 2026 Earnings EPS Beats Estimates Stock Jumps 6 UPBD Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction KLAR Q1 2026 Earnings Net Loss Narrows Sharply Beating Estimates by Wide Margin Strawberry Fields REIT STRW Modestly Advances as It Approaches Key Resistance Level Opendoor Technologies OPEN Jumps 6 as Home Resale Platform Shows Early Signs of Recovery Flaherty Crumrine Total Return Fund FLC Edges Higher as Investors Eye Income Opportunities Zymeworks Inc ZYME Faces Selling Pressure as Shares Dip 240 Key Levels in Focus Synaptics SYNA Slightly Lower as Stock Tests Key Support and Resistance Levels Perpetua Resources Secures 29 Billion US Loan to Develop Idaho GoldAntimony Project EVGN Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Spend Unilever UL Gains 163 Testing Resistance Near 609 STRF Preferred Stock Edges Lower as Price Holds Near Midpoint of Support and Resistance WEBTOON Entertainment Inc WBTN Gains 164 as Stock Approaches Key Resistance Zone Pitney Bowes Faces Resistance as Selling Pressure Intensifies Oscar Health OSCR Gains Ground Breaking Through Key Technical Levels Armada Acquisition Corp II Units XRPNU Holds Steady at 1088 Amid Low Volatility Perimeter Solutions SA PRM Edges Higher on Modest Gains as Shares Test Key Moving Averages Nektar Therapeutics NKTR Navigates a 287 Decline as Key Support Levels Come Into Focus